CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

A case control study on relation between the variations in platelet counts and mean platelet volume in type 2 diabetic patients on treatment and non-diabetic controls

Author: 
Dr. Tanvi Rajan Prabhu and Dr. Jayaraj R Mhetri
Subject Area: 
Health Sciences
Abstract: 

Background: It is observed that in diabetes there is an enhanced platelets activation and increase in coagulation proteins and fibrinolytic activity is reduced. These are the pro thrombotic states which further lead to the development of cardiovascular and atherosclerotic complications. Studies have indicated that the patients of Type 2 DM have two to four folds increase in risk of atherosclerosis. Mean Platelet Volume (MPV), which is the average volume of platelets and measures platelet size distribution, and is not influenced by glycemic control. Studies have shown that a higher incidence of proliferative diabetic retinopathy and myocardial infarction are associated with increased MPV. It is observed in the diabetics that larger than normal platelets are in circulation, this is due to the activated megakaryocyte-platelet system. Platelet count and MPV can prove to be an inexpensive, simple and effective tests that may be used to predict angiopathy in type 2 DM. Few studies have used Elevated MPV levels to predict bad outcome for acute ischemic cerebrovascular events independent of other clinical parameters. Aims and Objectives: To study the relation between the variations in platelet counts and mean platelet volume in type 2 diabetic patients on treatment and non-diabetic controls. Methods: Acase control study. Results: The overall mean platelet volume was 8.41±0.68fl, for the diabetics 8.72±0.71 fl and the non-diabetic controls 8.94±0.79 fl.There was a statistically significant difference in platelet count of diabetics and healthy controls platelet counts. p =0.049 and t value of 1.99. There was no statistically significant difference between the mean platelet volume in diabetics and healthy controlswith p=0.146 and t value of 1.46. Positive correlation was observed between MPV and fasting blood sugar (r = 0.027, p <0.001) when Pearson's correlation test was applied.Also, Body Mass Index (r =0.147) and duration of diabetics (r =0.026) were positively correlated.However, platelet count and fasting blood sugar were negatively co related (r = -0.048),Platelet count was also negatively correlated with duration of diabetics (r = -0.021). Platelet count and body mass index (r = 0.032) were positively correlated. In both the diabetic patients and non-diabetic controls the relation between the platelet count and mean platelet volume showed positive correlation, Pearson's test was used and it showed statistically significant levels of 0.041 in both groups. Conclusion: The present study showed that the diabetics on treatment had higher mean platelet count than that of non-diabetics controls, it was also noted that mean platelet volume was lower in controls than in cases.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran